Australie - anglais - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - amlodipine besilate, quantity: 13.867 mg (equivalent: amlodipine, qty 10 mg) - tablet, uncoated - excipient ingredients: mannitol; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate - hypertension: amlodipine gh tablets are indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoreceptor blocking agent or an angiotensin-converting enzyme inhibitor. angina: amlodipine gh tablets are indicated for the first line treatment of chronic stable angina. amlodipine gh tablets may be used alone, as monotherapy or in combination with other antianginal drugs.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - amlodipine besilate, quantity: 6.9335 mg (equivalent: amlodipine, qty 5 mg) - tablet, uncoated - excipient ingredients: mannitol; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate - hypertension: amlodipine gh tablets are indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoreceptor blocking agent or an angiotensin-converting enzyme inhibitor. angina: amlodipine gh tablets are indicated for the first line treatment of chronic stable angina. amlodipine gh tablets may be used alone, as monotherapy or in combination with other antianginal drugs.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - amlodipine besilate, quantity: 13.868 mg (equivalent: amlodipine, qty 10 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate; sodium starch glycollate type a; microcrystalline cellulose; magnesium stearate - hypertension: amlodipine-ga tablets are indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor. angina: amlodipine-ga tablets are indicated for the first line treatment of chronic stable angina. amlodipine-ga may be used alone, as monotherapy or in combination with other antianginal drugs.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - amlodipine besilate, quantity: 6.934 mg (equivalent: amlodipine, qty 5 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate; magnesium stearate; microcrystalline cellulose; sodium starch glycollate type a - hypertension: amlodipine-ga tablets are indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor. angina: amlodipine-ga tablets are indicated for the first line treatment of chronic stable angina. amlodipine-ga may be used alone, as monotherapy or in combination with other antianginal drugs.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - teriflunomide, quantity: 14 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate; microcrystalline cellulose; hyprolose; maize starch; lactose monohydrate; titanium dioxide; macrogol 8000; hypromellose; purified talc; indigo carmine aluminium lake - aubagio is indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - tamoxifen citrate, quantity: 30.4 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; lactose monohydrate; gelatin; titanium dioxide; maize starch; macrogol 300; hypromellose; magnesium stearate - treatment of breast cancer nolvadex-d is indicated for the treatment of breast cancer. primary reduction of breast cancer risk nolvadex-d is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

Australie - anglais - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - captopril, quantity: 25 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose; maize starch; stearic acid; sodium starch glycollate - hypertension. treatment of hypertension. in using zedace, consideration should be given to the risk of neutropenia/ agranulocytosis (see precautions). zedace is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the hypotensive effects of captopril and thiazides are approximately additive. myocardial infraction. zedace may be used to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction, manifested as an ejection fraction less than or equal to 40%, and to decrease the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. the efficacy data for the use of captopril following myocardial infarction are strongest for commencement of therapy beyond three days postinfarction. heart failure. treatment of heart failure. it is recommended that zedace be administered together with a diuretic in symptomatic patients. diabetic nephropathy. zedace is also indicated in the treatment of diabetic nephropathy in patients with type i insulin- dependent diabetes mellitus.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - teriflunomide, quantity: 14 mg - tablet - excipient ingredients: maize starch; magnesium stearate; hyprolose; silicon dioxide; lactose monohydrate; sodium starch glycollate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; indigo carmine aluminium lake - teriflunomide dr.reddy's is indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - teriflunomide, quantity: 14 mg - tablet - excipient ingredients: maize starch; lactose monohydrate; sodium starch glycollate; hyprolose; silicon dioxide; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; indigo carmine aluminium lake - apo-teriflunomide is indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - teriflunomide, quantity: 14 mg - tablet, film coated - excipient ingredients: maize starch; hyprolose; colloidal anhydrous silica; lactose monohydrate; sodium starch glycollate type a; magnesium stearate; microcrystalline cellulose; purified water; titanium dioxide; hypromellose; macrogol 8000; purified talc; indigo carmine aluminium lake - terimide is indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability